Although Yao et al. discovered that cyclin K controls the β-catenin/cyclin D1 axis as a significant mechanism in lung cancer, more investigation is needed to ascertain whether the distinct role of CCNK in nEAC is due to similar molecular connections. Here, CCNK is linked to lung cancer.